{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:39:51Z","timestamp":1776425991035,"version":"3.51.2"},"reference-count":26,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Placenta accreta spectrum (PAS) refers to the abnormal placental implantation into the uterine wall, and its incidence is rising in parallel with increasing cesarean deliveries and myomectomies. PAS carries high maternal risks, including hemorrhage, shock, and death. Management involves either a hysterectomy or conservative approaches to preserve fertility that come with higher risks of maternal morbidity and mortality. Radiofrequency ablation (RFA) is a well-established modality for treating soft tissue tumors, but its use for PAS is not well studied. Case: We report a case of successful postpartum treatment of placenta accreta with transcervical radiofrequency ablation, which preserved uterine integrity and resolved significant bleeding without postoperative complications. Conclusions: Transcervical RFA may offer a safe and minimally invasive treatment for placenta accreta that conserves the uterus and may maintain reproductive capacity.<\/jats:p>","DOI":"10.3390\/jcm15083066","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:11:04Z","timestamp":1776420664000},"page":"3066","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postpartum Management of Placenta Accreta with Transcervical Radiofrequency Ablation for Fertility Conservation"],"prefix":"10.3390","volume":"15","author":[{"given":"Nicole","family":"Santella","sequence":"first","affiliation":[{"name":"Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5800-7681","authenticated-orcid":false,"given":"David","family":"Toub","sequence":"additional","affiliation":[{"name":"Independent Gynecology and Medical Affairs Consultant\/Researcher, Wyncote, PA 19095, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Hansen Lindner","sequence":"additional","affiliation":[{"name":"Atrium Health, Carolinas Medical Center, Charlotte, NC 28204, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_2","unstructured":"Cahill, A., Beigi, R., Heine, P., and Silver Wax, J. (2026, January 07). Placenta Accreta Spectrum. ACOG Obstetric Care Consensus. Available online: https:\/\/www.acog.org\/clinical\/clinical-guidance\/obstetric-care-consensus\/articles\/2018\/12\/placenta-accreta-spectrum."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"839.e1","DOI":"10.1016\/j.ajog.2021.12.013","article-title":"Conservative management or cesarean hysterectomy for placenta accreta spectrum: The PACCRETA prospective study","volume":"226","author":"Sentilhes","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"534.e1","DOI":"10.1016\/j.ajog.2021.04.233","article-title":"Trends, characteristics, and outcomes of placenta accreta spectrum: A national study in the United States","volume":"225","author":"Matsuzaki","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.carj.2014.11.005","article-title":"The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study","volume":"66","author":"Chan","year":"2015","journal-title":"Can. Assoc. Radiol. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/bjs.9960","article-title":"Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas","volume":"103","author":"Kim","year":"2016","journal-title":"Br. J. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.suc.2015.12.006","article-title":"Hepatic Tumor Ablation","volume":"96","author":"Ziemlewicz","year":"2016","journal-title":"Surg. Clin. North. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s13669-022-00341-8","article-title":"Transcervical Fibroid Ablation (TFA) with the Sonata System: Updated Review of a New Paradigm for Myoma Treatment","volume":"11","author":"Roy","year":"2022","journal-title":"Curr. Obstet. Gynecol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Stewart, K.A., Greenberg, J.A., Kho, K.A., and Cohen Rassier, S.L. (2023). Radiofrequency Ablation of Leiomyomas. Obstet Gynecol.","DOI":"10.1097\/AOG.0000000000005196"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13669-017-0194-2","article-title":"A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata System","volume":"6","author":"Toub","year":"2017","journal-title":"Curr. Obs. Gynecol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13669-024-00403-z","article-title":"Transcervical Fibroid Ablation (TFA): Current Status and New Developments","volume":"13","author":"Roy","year":"2024","journal-title":"Curr. Obstet. Gynecol. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Dedes, I., Kolovos, G., Arrigo, F., Toub, D., Vaineau, C., Lanz, S., Imboden, S., Feki, A., and Mueller, M.D. (2023). Radiofrequency Ablation for Adenomyosis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12093069"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1471-0528.2009.02166.x","article-title":"Radiofrequency ablation of retained placenta accreta after conservative management: Preliminary evaluation in the pregnant ewe and in normal human placenta in vitro","volume":"116","author":"Morel","year":"2009","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejogrb.2019.07.017","article-title":"Radiofrequency ablation of retained placenta accreta after conservative management","volume":"240","author":"Katsogiannou","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10397-014-0873-1","article-title":"Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate\u00ae System: Three- and six-month endpoint results from the FAST-EU study","volume":"12","author":"Bongers","year":"2015","journal-title":"Gynecol. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10397-015-0915-3","article-title":"The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids","volume":"13","author":"Bongers","year":"2016","journal-title":"Gynecol. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10397-010-0655-3","article-title":"Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate System: Safety, tolerability, and ablation results in a closed abdomen setting","volume":"8","author":"Toub","year":"2011","journal-title":"Gynecol. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijgo.12948","article-title":"A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta","volume":"147","author":"Serruya","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/aogs.12080","article-title":"Placenta accreta: Incidence and risk factors in an area with a particularly high rate of cesarean section","volume":"92","author":"Morlando","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejogrb.2013.08.030","article-title":"Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section","volume":"171","author":"Higgins","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/FM9.0000000000000077","article-title":"Placenta Accreta Spectrum: Conservative Management and Its Impact on Future Fertility","volume":"3","author":"Abbas","year":"2021","journal-title":"Matern. Fetal Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.14867","article-title":"High-intensity focused ultrasound treatment of placenta accreta after vaginal delivery: A preliminary study","volume":"47","author":"Bai","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1471-0528.14743","article-title":"High-intensity focused ultrasound combined with hysteroscopic resection for the treatment of placenta accreta","volume":"124","author":"Ye","year":"2017","journal-title":"BJOG"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/02656736.2021.1887943","article-title":"Early versus late hysteroscopic resection after high-intensity focused ultrasound for retained placenta accreta","volume":"38","author":"He","year":"2021","journal-title":"Int. J. Hyperth."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5005\/jp-journals-10006-1330","article-title":"Medical Management of Placenta Accreta with Methotrexate: Review of Two Cases","volume":"7","author":"Singh","year":"2015","journal-title":"J. South. Asian Fed. Obstet. Gynaecol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Hansen-Lindner, L., Schmid-Lossberg, J., and Toub, D. (2024). Transcervical Fibroid Ablation (TFA): Update on Pregnancy Outcomes. J. Clin. Med., 13.","DOI":"10.3390\/jcm13102892"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/3066\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:39:57Z","timestamp":1776422397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/3066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["jcm15083066"],"URL":"https:\/\/doi.org\/10.3390\/jcm15083066","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]}}}